ScholarLens Back to search
2017•Journal of Medicine and PharmacyRequires access

TREATMENT OF CHRONIC HEPATITIS C GENOTYPE 6 PATIENT WITH TRIPLE THERAPY PEG-IFN, RIBAVIRIN AND SOFOSBUVIR: CASE REPORT AND REVIEW OF LITERATURE

Xuan Chuong Tran

Open publisher page 0 citations

Abstract

The author presents a case with chronic hepatitis C, genotype 6, treated with triple regime: Peg-IFN combined to ribavirin and sofosbuvir. After 3 months of therapy and 3 months follow up, patient has good clinical and virological response (SVR 12). Some results of similar studies in Vietnam and abroad, especially the studies concerning the new agents DAAs were also presented, analysed and compared with author’s results. Key words: Hepatitis C, treatment, Peg-IFN, Ribavirin, Sofosbuvir

About this research paper

What this paper is about

The author presents a case with chronic hepatitis C, genotype 6, treated with triple regime: Peg-IFN combined to ribavirin and sofosbuvir. After 3 months of therapy and 3 months follow up, patient has good clinical and virological response (SVR 12). Some results of similar studies in Vietnam and abroad, especially the studies concerning the new agents DAAs were also presented, analysed and compared with author’s results. Key words: Hepatitis C, treatment, Peg-IFN, Ribavirin, Sofosbuvir

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The author presents a case with chronic hepatitis C, genotype 6, treated with triple regime: Peg-IFN combined to ribavirin and sofosbuvir. After 3 months of therapy and 3 months follow up, patient has good clinical and virological response (SVR 12). Some results of similar studies in Vietnam and abroad, especially the studies concerning the new agents DAAs were also presented, analysed and compared with author’s results. Key words: Hepatitis C, treatment, Peg-IFN, Ribavirin, Sofosbuvir

Key concepts: Ribavirin, Sofosbuvir, Medicine, Chronic hepatitis, Hepatitis C, Pegylated interferon, Virology, Genotype

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
TREATMENT OF CHRONIC HEPATITIS C GENOTYPE 6 PATIENT WITH TRIPLE THERAPY PEG-IFN, RIBAVIRIN AND SOFOSBUVIR: CASE REPORT AND REVIEW OF LITERATURE — Research Paper | ScholarLens